Publications by authors named "L Wiesner"

Claim this Profile
F
Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.
Anushka Naidoo, Kogieleum Naidoo, Marothi P Letsoalo, Roeland E Wasmann, Gillian Dorse, Lubbe Wiesner

Lancet HIV· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in Participants with HIV-associated Tuberculosis.
Rephaim Mpofu, Nomathemba Chandiwana, Simiso Sokhela, Michelle Moorhouse, Francois Venter, Lubbe Wiesner

J Acquir Immune Defic Syndr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin-resistant tuberculosis.
Sharon Sawe, Lufina Tsirizani, Buyisile Mkhize, Lubbe Wiesner, Gary Maartens

Br J Clin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Dexamethasone in Tuberculous Meningitis.
Jose M Calderin, Juan Eduardo Resendiz-Galvan, Noha Abdelgawad, Angharad Davis, Cari Stek, Lubbe Wiesner

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards effective cystic fibrosis gene therapy by optimizing prime editing and pulmonary-targeted LNPs.
Kaya Sophie Lange, Lisa Marie Wiesner, Kathleen Susat, Vera Köhler, Malte Lenger

Front Syst Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis